Literature DB >> 23297166

Theophylline cocrystals prepared by spray drying: physicochemical properties and aerosolization performance.

Amjad Alhalaweh1, Waseem Kaialy, Graham Buckton, Hardyal Gill, Ali Nokhodchi, Sitaram P Velaga.   

Abstract

The purpose of this work was to characterize theophylline (THF) cocrystals prepared by spray drying in terms of the physicochemical properties and inhalation performance when aerosolized from a dry powder inhaler. Cocrystals of theophylline with urea (THF-URE), saccharin (THF-SAC) and nicotinamide (THF-NIC) were prepared by spray drying. Milled THF and THF-SAC cocrystals were also used for comparison. The physical purity, particle size, particle morphology and surface energy of the materials were determined. The in vitro aerosol performance of the spray-dried cocrystals, drug-alone and a drug-carrier aerosol, was assessed. The spray-dried particles had different size distributions, morphologies and surface energies. The milled samples had higher surface energy than those prepared by spray drying. Good agreement was observed between multi-stage liquid impinger and next-generation impactor in terms of assessing spray-dried THF particles. The fine particle fractions of both formulations were similar for THF, but drug-alone formulations outperformed drug-carrier formulations for the THF cocrystals. The aerosolization performance of different THF cocrystals was within the following rank order as obtained from both drug-alone and drug-carrier formulations: THF-NIC>THF-URE>THF-SAC. It was proposed that micromeritic properties dominate over particle surface energy in terms of determining the aerosol performance of THF cocrystals. Spray drying could be a potential technique for preparing cocrystals with modified physical properties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23297166      PMCID: PMC3581642          DOI: 10.1208/s12249-012-9883-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  25 in total

1.  The effect of mechanical processing on surface stability of pharmaceutical powders: visualization by atomic force microscopy.

Authors:  Philippe Begat; Paul M Young; Stephen Edge; J Sebastian Kaerger; Robert Price
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

2.  A comparison of morphology and surface energy characteristics of sulfathiazole polymorphs based upon single particle studies.

Authors:  Jennifer C Hooton; Caroline S German; Martyn C Davies; Clive J Roberts
Journal:  Eur J Pharm Sci       Date:  2006-03-28       Impact factor: 4.384

3.  Elucidating raw material variability--importance of surface properties and functionality in pharmaceutical powders.

Authors:  Sai P Chamarthy; Rodolfo Pinal; M Teresa Carvajal
Journal:  AAPS PharmSciTech       Date:  2009-06-05       Impact factor: 3.246

4.  Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan.

Authors:  Amjad Alhalaweh; Annamaria Vilinska; Elisabetta Gavini; Giovanna Rassu; Sitaram P Velaga
Journal:  AAPS PharmSciTech       Date:  2011-09-15       Impact factor: 3.246

5.  Hansen solubility parameter as a tool to predict cocrystal formation.

Authors:  Mohammad Amin Mohammad; Amjad Alhalaweh; Sitaram P Velaga
Journal:  Int J Pharm       Date:  2011-01-21       Impact factor: 5.875

6.  Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.

Authors:  X M Zeng; G P Martin; S K Tee; A A Ghoush; C Marriott
Journal:  Int J Pharm       Date:  1999-05-25       Impact factor: 5.875

7.  Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy.

Authors:  A M C Cassidy; C E Gardner; W Jones
Journal:  Int J Pharm       Date:  2009-06-17       Impact factor: 5.875

8.  Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.

Authors:  Srinivas Basavoju; Dan Boström; Sitaram P Velaga
Journal:  Pharm Res       Date:  2007-08-17       Impact factor: 4.200

9.  pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.

Authors:  Amjad Alhalaweh; Lilly Roy; Naír Rodríguez-Hornedo; Sitaram P Velaga
Journal:  Mol Pharm       Date:  2012-08-23       Impact factor: 4.939

10.  Pharmaceutical Cocrystals and Their Physicochemical Properties.

Authors:  Nate Schultheiss; Ann Newman
Journal:  Cryst Growth Des       Date:  2009-04-20       Impact factor: 4.076

View more
  7 in total

Review 1.  Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.

Authors:  Dipak Dilip Gadade; Sanjay Sudhakar Pekamwar
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 2.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

3.  Exploring the cocrystallization potential of urea and benzamide.

Authors:  Piotr Cysewski; Maciej Przybyłek; Dorota Ziółkowska; Karina Mroczyńska
Journal:  J Mol Model       Date:  2016-04-06       Impact factor: 1.810

Review 4.  Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2016-10-27

Review 5.  Particle engineering in pharmaceutical solids processing: surface energy considerations.

Authors:  Daryl R Williams
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline.

Authors:  Si Nga Wong; Jingwen Weng; Ignatius Ip; Ruipeng Chen; Richard Lakerveld; Richard Telford; Nicholas Blagden; Ian J Scowen; Shing Fung Chow
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

7.  Continuous Manufacture and Scale-Up of Theophylline-Nicotinamide Cocrystals.

Authors:  Steven A Ross; Andrew P Hurt; Milan Antonijevic; Nicolaos Bouropoulos; Adam Ward; Pat Basford; Mark McAllister; Dennis Douroumis
Journal:  Pharmaceutics       Date:  2021-03-20       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.